Michael T. Lotze

发表

IL-4 regulates IL-2 induction of lymphokine-activated killer activity from human lymphocytes.

S. Rosenberg, M. Lotze, Y. Kawakami, 1989, Journal of immunology.

Lymphokine-activated killer (LAK) cell phenomenon. IV. Lysis by LAK cell clones of fresh human tumor cells from autologous and multiple allogeneic tumors.

S. Rosenberg, M. Lotze, E. Grimm, 1985, Journal of the National Cancer Institute.

Dermatologic changes associated with interleukin 2 administration.

S. Rosenberg, M. Lotze, A. Gaspari, 1987, JAMA.

In vitro growth of cytotoxic human lymphocytes. II. Use of T cell growth factor (TCGF) to clone human T cells.

S. Rosenberg, M. Lotze, J. Strausser, 1980, Journal of immunology.

Interleukin-2 induces profound reversible cholestasis: a detailed analysis in treated cancer patients.

B. Garra, S. Steinberg, J. Hoofnagle, 1989, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Human gene transfer: characterization of human tumor-infiltrating lymphocytes as vehicles for retroviral-mediated gene transfer in man.

K. Cornetta, W. Anderson, M. Lotze, 1990, Proceedings of the National Academy of Sciences of the United States of America.

Separation and functional studies of the human lymphokine-activated killer cell.

S. Rosenberg, M. Lotze, K. Roberts, 1987, Cancer research.

Human gene marker/therapy clinical protocols.

K. Cornetta, J. Roth, R. Crystal, 1996, Human gene therapy.

Development of hepatocellular carcinoma among patients with chronic liver disease due to hepatitis C viral infection.

J. Hoofnagle, A. D. Di Bisceglie, M. Lotze, 1994, Journal of clinical gastroenterology.

IL-6/IFN-beta-2 as a circulating hormone. Induction by cytokine administration in humans.

S. Rosenberg, M. Lotze, J. Mulé, 1989, Journal of immunology.

IL-2-based immunotherapy alters circulating neutrophil Fc receptor expression and chemotaxis.

S. Rosenberg, M. Lotze, D. Jablons, 1990, Journal of immunology.

This information is current as Lymphocytes + / IDO + Stromal Cell Induction of IL-10 S 100 A 4 and Uric Acid Promote Mesenchymal

M. Rojewski, R. Lotfi, C. Kaltenmeier, 2014 .

Interleukin 2 and psoriasis.

A. Chang, S. Rosenberg, M. Lotze, 1988, Archives of dermatology.

A new approach to the therapy of cancer based on the systemic administration of autologous lymphokine-activated killer cells and recombinant interleukin-2.

A. Chang, S. Rosenberg, M. Lotze, 1986, Surgery.